Drug Type Autologous CAR-T |
Synonyms A CAR028 |
Target |
Action inhibitors |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory acute myeloid leukemia | Phase 1 | China | 30 Sep 2025 | |
| Relapsing acute myeloid leukemia | Phase 1 | China | 30 Sep 2025 | |
| Acute Myeloid Leukemia | Preclinical | United States | 01 Mar 2025 |





